WuXi Biologics (Cayman) Inc. Stock OTC Markets
Stocks
WXXW.Y
US98260N1081
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.868 USD | +1.12% |
|
-12.98% | -3.47% |
| Jun. 05 | Wuxi Biologics Completes Topping Out of Drug Product Facility At Singapore Crdmo Hub | CI |
| May. 31 | Wuxi Biologics adds 69 projects in Jan-April, maintains expected revenue growth | RE |
| Market Cap | 107B 15.79B 13.68B 12.59B 11.84B 22.03B 1,509B 22.37B 149B 58.03B 728B 59.29B 58.01B 2,528B | P/E ratio 2026 * |
19.8x | P/E ratio 2027 * | 16.4x |
|---|---|---|---|---|---|
| Enterprise value | 95.79B 14.13B 12.24B 11.26B 10.59B 19.71B 1,350B 20.01B 133B 51.92B 651B 53.05B 51.9B 2,262B | EV / Sales 2026 * |
3.8x | EV / Sales 2027 * | 3.13x |
| Free-Float |
90.02% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: WuXi Biologics (Cayman) Inc.
| 1 day | -0.74% | ||
| 1 week | -12.98% | ||
| Current month | -11.03% | ||
| 1 month | -7.63% | ||
| 3 months | -15.14% | ||
| 6 months | -8.07% | ||
| Current year | -3.47% |
| 1 week | 7.45 |  | 8.69 |
| 1 month | 7.45 | | 9.12 |
| Current year | 7.45 | | 10.84 |
| 1 year | 6.02 | | 11.21 |
| 3 years | 2.58 | | 13.25 |
| 5 years | 2.58 | | 38 |
| 10 years | 2.58 | | 43.36 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zhi Sheng Chen
CEO | Chief Executive Officer | 54 | 2015-12-31 |
Ming Tu
DFI | Director of Finance/CFO | 56 | 2021-08-22 |
Xuejun Gu
CTO | Chief Tech/Sci/R&D Officer | 55 | 2024-03-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Ge Li
CHM | Chairman | 59 | 2014-01-31 |
Zhi Sheng Chen
BRD | Director/Board Member | 54 | 2014-01-31 |
Yan Ling Cao
BRD | Director/Board Member | 42 | 2016-04-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.12% | -12.98% | - | - | 16.03B | |
| +0.39% | +10.40% | +49.24% | +110.21% | 54.81B | |
| -0.58% | -3.99% | +50.00% | +49.74% | 42.96B | |
| +0.78% | -3.34% | -20.93% | -21.14% | 21.62B | |
| +4.09% | -5.35% | +38.91% | +395.86% | 20.41B | |
| +0.06% | +3.76% | +7.19% | -40.12% | 15.28B | |
| +1.58% | +8.18% | +22.34% | +173.49% | 13.01B | |
| +1.41% | -4.01% | +12.62% | - | 11.37B | |
| +2.45% | -3.13% | -33.23% | +722.57% | 10.95B | |
| -1.17% | -3.74% | +102.29% | +204.48% | 10.9B | |
| Average | +0.81% | -3.78% | +25.38% | +199.39% | 22.37B | |
| Weighted average by Cap. | +0.63% | -1.99% | +32.21% | +145.24% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 25.22B 3.72B 3.22B 2.97B 2.79B 5.19B 355B 5.27B 35.06B 13.67B 172B 13.97B 13.66B 596B | 29.59B 4.36B 3.78B 3.48B 3.27B 6.09B 417B 6.18B 41.14B 16.04B 201B 16.39B 16.03B 699B |
| Net income | 5.5B 811M 702M 646M 608M 1.13B 77.46B 1.15B 7.64B 2.98B 37.37B 3.04B 2.98B 130B | 6.65B 981M 850M 782M 735M 1.37B 93.76B 1.39B 9.25B 3.61B 45.24B 3.68B 3.6B 157B |
| Net Debt | -11.28B -1.66B -1.44B -1.33B -1.25B -2.32B -159B -2.36B -15.68B -6.11B -76.69B -6.25B -6.11B -266B | -14.43B -2.13B -1.84B -1.7B -1.6B -2.97B -203B -3.01B -20.06B -7.82B -98.12B -7.99B -7.82B -341B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-09 | 7.868 $ | +1.12% | 7,047 |
| 26-06-08 | 7.780 $ | -4.89% | 94,483 |
| 26-06-05 | 8.180 $ | -0.73% | 38,016 |
| 26-06-04 | 8.240 $ | +0.37% | 72,685 |
| 26-06-03 | 8.210 $ | -7.48% | 37,239 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2269 Stock
- WXXW.Y Stock
Select your edition
All financial news and data tailored to specific country editions
